These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 26639682)

  • 21. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
    Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
    CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of different forms of naltrexone in the treatment of opioid dependence].
    Krupitskiĭ EM; Zvartau EE; Blokhina EA; Woody G
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 2):66-72. PubMed ID: 22611701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based pharmacogenetics: Is it possible?
    Sychev DA; Malova EU
    Int J Risk Saf Med; 2015; 27 Suppl 1():S97-8. PubMed ID: 26639733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonist Models for Relapse Prevention and Reducing HIV Risk.
    Woody GE; Krupitsky E; Zvartau E
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):401-7. PubMed ID: 26922659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furthering benefit/risk ratio and cost effectiveness of anticancer drugs.
    Golikov AS; Tikhomirova AV
    Int J Risk Saf Med; 2015; 27 Suppl 1():S49-50. PubMed ID: 26639707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of alcohol dependence: rational and arguable approaches].
    Sivolap IuP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5 Pt 2):53-6. PubMed ID: 24988976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapy of dual substance abuse and dependence.
    Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
    CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
    Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
    Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care.
    Park TW; Samet JH; Cheng DM; Winter MR; Kim TW; Fitzgerald A; Saitz R
    J Subst Abuse Treat; 2015 May; 52():17-23. PubMed ID: 25524751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapeutic options for co-morbid depression and alcohol dependence.
    Hillemacher T; Frieling H
    Expert Opin Pharmacother; 2019 Apr; 20(5):547-569. PubMed ID: 30602322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of alcohol dependence].
    Trova AC; Paparrigopoulos T; Liappas I; Ginieri-Coccossis M
    Psychiatriki; 2015; 26(2):131-40. PubMed ID: 26197102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tianeptine and alcohol dependence.
    Favre JD; Guelfi-Sozzi C; Delalleau B; Lôo H
    Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S347-51. PubMed ID: 9405962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Management of Physician-delivered Alcohol Care for Tuberculosis Patients: Design and Implementation.
    Greenfield SF; Shields A; Connery HS; Livchits V; Yanov SA; Lastimoso CS; Strelis AK; Mishustin SP; Fitzmaurice G; Mathew TA; Shin S
    Alcohol Clin Exp Res; 2010 Feb; 34(2):317-30. PubMed ID: 19930235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of alcohol use disorders in ambulatory care: Which follow-up and for how long?].
    Benyamina A; Reynaud M
    Encephale; 2016 Feb; 42(1):67-73. PubMed ID: 26796554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
    Torrens M; Fonseca F; Mateu G; Farré M
    Drug Alcohol Depend; 2005 Apr; 78(1):1-22. PubMed ID: 15769553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.
    Soyka M
    CNS Drugs; 1997 Apr; 7(4):313-27. PubMed ID: 27520754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence.
    Davoli M; Amato L; Clark N; Farrell M; Hickman M; Hill S; Magrini N; Poznyak V; Schünemann HJ
    Addiction; 2015 Jun; 110(6):891-8. PubMed ID: 25490943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy of alcoholism in patients with co-morbid psychiatric disorders.
    Goldstein BI; Diamantouros A; Schaffer A; Naranjo CA
    Drugs; 2006; 66(9):1229-37. PubMed ID: 16827599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Opioid System and Food Intake: Use of Opiate Antagonists in Treatment of Binge Eating Disorder and Abnormal Eating Behavior.
    Valbrun LP; Zvonarev V
    J Clin Med Res; 2020 Feb; 12(2):41-63. PubMed ID: 32095174
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.